tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN

Regeneron (REGN) Stock News & Sentiment

3,951 Followers
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
PremiumPress Releases
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
3d ago
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
PremiumPress Releases
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
8d ago
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
PremiumPress Releases
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
17d ago
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
PremiumPress Releases
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
21d ago
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
PremiumPress Releases
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
23d ago
Regeneron (NASDAQ:REGN) Accused of Manipulating Pricing
PremiumMarket News
Regeneron (NASDAQ:REGN) Accused of Manipulating Pricing
1M ago
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
PremiumPress Releases
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
1M ago
More REGN News >

News Score - Last 7 Days

Neutral
REGN
Sector Average
Media Buzz
This Week18 articles
Weekly Average18.5 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?
18 articles about REGN were published this week. In an average week, 18.5 articles are published.
    What is REGN’s weekly average amount of articles?
    In an average week, 18.5 articles about REGN are published.
      What is REGN’s News Sentiment?
      100% of articles about REGN were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        MTDMettler-Toledo
        SYRESpyre Therapeutics
        CRNXCrinetics Pharmaceuticals
        PYXSPyxis Oncology
        HAEHaemonetics
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis